NASP: National Association of Specialty Pharmacy Releases Agenda for Fifth Annual Specialty Pharmacy Law Conference
The conference will take place virtually in conjunction with the eighth NASP Annual Meeting & Expo Virtual Experience Read More »
The conference will take place virtually in conjunction with the eighth NASP Annual Meeting & Expo Virtual Experience Read More »
New Board Members Also Announced, Including Representatives from AstraZeneca, UCB, and US Bioservices2019-2020 NASP President-Elect Announced Read More »
The National Association of Specialty Pharmacy (NASP) is extremely disappointed the administration did not initiate much needed reforms to ensure Medicare beneficiaries begin paying less at the pharmacy counter in 2020. Read More »
New data presented and simultaneously published in the Journal of the American College of Cardiology show treatment with MitraClip resulted in significant and sustained long-term quality-of-life improvements compared to medical therapy Read More »
Health information technology (IT) should be the foundation of all business and clinical operations and not a secondary byproduct Read More »
Rite Aid Corporation (NYSE: RAD) released the following statement praising the U.S. Senate for passage of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (H.R. 6). Read More »
Rite Aid Corporation (NYSE: RAD) announced that the company has established its Chemical Policy and expanded Restricted Substances List as part of ongoing efforts to continue meeting customer expectations for chemical management and product safety. Read More »
Rite Aid Corporation (NYSE: RAD) announced today that DisposeRx, a first-of-its-kind opioid disposal solution, is now available at all of Rite Aid's more than 2,500 pharmacies across the United States. Read More »
The Rite Aid Foundation recently announced the rollout of its KidCents Safe Medication Disposal Program, which will focus on reducing drug accessibility, medication misuse and accidental poisoning of children and adolescents. Read More »
Abbott recently announced the initiation of a pivotal clinical study based in the United States that will assess the safety and efficacy of a modified version of its Amplatzer device. Read More »
Regional Cancer Care Associates (RCCA) recently announced its attainment of accreditation by URAC, a leading nonprofit health care benchmark group, as a Specialty Pharmacy in Hackensack, New Jersey. Read More »
National Association of Specialty Pharmacy Executive Director Sheila Arquette recently responded to a report on direct and indirect remuneration fees commissioned by the Pharmaceutical Care Management Association. Read More »
Formulated to detect the presence of the potent opioid fentany in urine, California-based Immunalysis Corp.’s branded immunoassay Sefria — the first of its kind — recently achieved 510(k) clearance from the U.S. Food and Drug Administration. Read More »
Test detects five most commonly misused and abused prescription drugs; five-minute results will facilitate rapid interventions in prescription drug abuse. Read More »
eFFECTOR Therapeutics recently presented Phase 1 clinical trial data for its lead product candidate, eFT508, at the 2017 American Society of Clinical Oncology annual meeting in Chicago. Read More »
Do television ads by plaintiffs' lawyer firms hawking lawsuits over prescription drugs cause patients to cease taking their prescribed prescriptions? Read More »
Abbott recently announced that its molecular test, the Abbott RealTime Zika Test, has been authorized by the U.S. Food and Drug Administration (FDA). Read More »
Good Day Pharmacy COO, Vicki Einhellig took place in the recent National Community Pharmacists Association's Steering Committee Forum from April 25-26. Read More »
The Academy of Managed Care Pharmacy's members are urging Congress and President Donald Trump's administration to include comprehensive pharmacy benefits in any health care reform bill they attempt to pass. Read More »
The Academy of Managed Care Pharmacy (AMCP) recently applauded Rep. Brett Guthrie's (R-KY) Pharmaceutical Information Exchange (PIE) Act of 2017 and its efforts toward its passage. Read More »